Frequent pathway mutations of splicing machinery in myelodysplasia

Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles

Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625

Sequencing technologies – the next generation

Metzker, M. L. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2626 · Cited by 7,066

Next-generation DNA sequencing

Shendure, J., & Ji, H. (2008) · Nature Biotechnology · doi:10.1038/nbt1486 · Cited by 4,509

The Spliceosome: Design Principles of a Dynamic RNP Machine

Wahl, M. C., Will, C. L., & Lührmann, R. (2009) · Cell · doi:10.1016/j.cell.2009.02.009 · Cited by 2,665

Recurring mutations found by sequencing an acute myeloid leukemia genome

Mardis, E. R., Ding, L., Dooling, D. J., Larson, D. E., McLellan, M. D., Chen, K., Koboldt, D. C., Fulton, R. S., Delehaunty, K. D., McGrath, S. D., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0903840 · Cited by 2,219

DNMT3A Mutations in Acute Myeloid Leukemia

Ley, T. J., Ding, L., Walter, M. J., McLellan, M. D., Lamprecht, T., Larson, D. E., Kandoth, C., Payton, J. E., Baty, J., Welch, J., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1005143 · Cited by 1,983

Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin

Morin, R. D., Johnson, N. A., Severson, T., Mungall, A. J. J., An, J., Goya, R., Paul, J. E., Boyle, M., Woolcock, B. W., Kuchenbauer, F. C., et al. (2010) · Nature Genetics · doi:10.1038/ng.518 · Cited by 1,719

Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia

Puente, X. S., Pinyol, M., Quesada, V., Conde, L., Ordóñez, G. R., Villamor, N., Escaramís, G., Jares, P., Beà, S., González, M., et al. (2011) · Nature · doi:10.1038/nature10113 · Cited by 1,529

Initial genome sequencing and analysis of multiple myeloma

Chapman, M. A., Lawrence, M. S., Keats, J. J., Cibulskis, K., Sougnez, C. L., Schinzel, A. C., Harview, C. L., Brunet, J.-P., Ahmann, G. J., Adli, M., et al. (2011) · Nature · doi:10.1038/nature09837 · Cited by 1,457

DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome

Ley, T. J., Mardis, E. R., Ding, L., Fulton, B., McLellan, M. D., Chen, K., Dooling, D. J., Dunford-Shore, B. H., McGrath, S. D., Hickenbotham, M. T., et al. (2008) · Nature · doi:10.1038/nature07485 · Cited by 1,434

Spliceosome mutations in myelodysplastic syndromes and chronic myelomonocytic leukemia

Chesnais, V., Kosmider, O., Damm, F., Itzykson, R., Bernard, O., Solary, É., & Fontenay, M. (2012) · Oncotarget · doi:10.18632/oncotarget.749 · Cited by 25

The prognostic implication of SRSF2 mutations in Chinese patients with acute myeloid leukemia

Yang, J. C., Yao, D., Ma, J., Yang, L., Guo, H. Y., Wen, X., Xiao, G.-F., Qian, Z. Y., Lin, J., & Qian, J. (2016) · Tumor Biology · doi:10.1007/s13277-015-4716-0 · Cited by 24

IDH1 Mutation Is an Independent Inferior Prognostic Indicator for Patients with Myelodysplastic Syndromes

Wang, N., Wang, F., Shan, N., Sui, X., & Xu, H. (2017) · Acta Haematologica · doi:10.1159/000479546 · Cited by 25

Altered EZH2 splicing and expression is associated with impaired histone H3 lysine 27 tri-Methylation in myelodysplastic syndrome

Shirahata‐Adachi, M., Iriyama, C., Tomita, A., Suzuki, Y., Shimada, K., & Kiyoi, H. (2017) · Leukemia Research · doi:10.1016/j.leukres.2017.10.015 · Cited by 25

Cyclin-dependent kinase 1 (CDK1) and CDK2 have opposing roles in regulating interactions of splicing factor 3B1 with chromatin

Murthy, T., Bluemn, T., Gupta, A. K., Reimer, M. H., Rao, S., Pillai, M. M., & Minella, A. C. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.001654 · Cited by 26

SRSF2 mutations in myelodysplasia/myeloproliferative neoplasms

Aujla, A. S., Linder, K. J., Iragavarapu, C., Karass, M., & Liu, D. (2018) · Biomarker Research · doi:10.1186/s40364-018-0142-y · Cited by 25

Identification of a noncanonical RNA binding domain in the U2 snRNP protein SF3A1

Martelly, W., Fellows, B., Senior, K., Marlowe, T. A., & Sharma, S. (2019) · RNA · doi:10.1261/rna.072256.119 · Cited by 24

Prognostic value of U2AF1 mutant in patients with de novo myelodysplastic syndromes: a meta-analysis

Wang, H., Zhang, N., Wu, X., Zheng, X. Y., Ling, Y., & Gong, Y. (2019) · Annals of Hematology · doi:10.1007/s00277-019-03843-3 · Cited by 24

Targeting TP53 Mutations in Myelodysplastic Syndromes

Hunter, A. M., & Sallman, D. A. (2019) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2019.11.004 · Cited by 25

The Genomics of Myelodysplastic Syndromes: Origins of Disease Evolution, Biological Pathways, and Prognostic Implications

Awada, H. K., Thapa, B., & Visconte, V. (2020) · Cells · doi:10.3390/cells9112512 · Cited by 26

Ets1 and heat shock factor 1 regulate transcription of the Transformer 2β gene in human colon cancer cells

Kajita, K., Kuwano, Y., Kitamura, N., Satake, Y., Nishida, K., Kurokawa, K., Akaike, Y., Honda, M., Masuda, K., & Rokutan, K. (2013) · Journal of Gastroenterology · doi:10.1007/s00535-012-0745-2 · Cited by 24

Systematic transcriptome analysis associated with physiological and chronological aging inCaenorhabditis elegansPreprint

Ham, S., Kim, S. S., Park, S., Kim, E. J. E., Kwon, S., Park, H. H., Jung, Y., & Lee, S. (2022) · Genome Research · doi:10.1101/gr.276515.121 · Cited by 24

Noncoding RNA mutations in cancer

Zhou, H., Hao, X., Zhang, P., & He, S. (2023) · WIREs RNA · doi:10.1002/wrna.1812 · Cited by 24

Genomic tools in acute myeloid leukemia: From the bench to the bedside

White, B. S., & DiPersio, J. F. (2014) · Cancer · doi:10.1002/cncr.28552 · Cited by 23

Deregulation of Genes Related to Iron and Mitochondrial Metabolism in Refractory Anemia with Ring Sideroblasts

Rey, M. D., Benito, R., Fontanillo, C., Campos-Laborie, F. J., Janusz, K., Velasco-Hernández, T., Abáigar, M., Hernández‐Sánchez, M., Cuello, R., Borrego, D., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126555 · Cited by 23

TET2 expression level and 5-hydroxymethylcytosine are decreased in refractory cytopenia of childhood

Coutinho, D. F., Monte-Mór, B. D. C. R., Vianna, D. T., Rouxinol, S. T., Batalha, A. B. W., Bueno, A. P. S., de Azevedo, A. M. B., Fernandez, T. D. S., Pombo‐de‐Oliveira, M. S., Gutiyama, L. M., et al. (2015) · Leukemia Research · doi:10.1016/j.leukres.2015.07.005 · Cited by 24

Total Synthesis of 6-Deoxypladienolide D and Assessment of Splicing Inhibitory Activity in a Mutant SF3B1 Cancer Cell Line

Arai, K., Buonamici, S., Chan, B., Corson, L., Endo, A., Gerard, B., Hao, M., Karr, C. D., Kira, K., Lee, L., et al. (2014) · Organic Letters · doi:10.1021/ol502556c · Cited by 23

Insight into the molecular pathophysiology of myelodysplastic syndromes: targets for novel therapy

Zahid, M. F., Patnaik, M. M., Gangat, N., Hashmi, S. K., & Rizzieri, D. A. (2016) · European Journal Of Haematology · doi:10.1111/ejh.12771 · Cited by 24

The Deubiquitinase USP39 Promotes ESCC Tumorigenesis Through Pre-mRNA Splicing of the mTORC2 Component Rictor

Zhao, Y., Geng, H., Liu, G., Ji, Q., Cheng, X., Li, X., Liu, W., Thorne, R. F., Zhang, R., & Liu, X. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.667495 · Cited by 23

U2AF1 mutation promotes tumorigenicity through facilitating autophagy flux mediated by FOXO3a activation in myelodysplastic syndromes

Zhu, Y., Song, D., Guo, J., Jin, J., Tao, Y., Zhang, Z., Xu, F., He, Q., Li, X., Chang, C., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03573-3 · Cited by 23

Inhibition of CDK9 activity compromises global splicing in prostate cancer cells

Hu, Q., Poulose, N., Girmay, S., Helevä, A., Doultsinos, D., Gondane, A., Steele, R. E., Liu, X., Loda, M. F., Liu, S., et al. (2021) · RNA Biology · doi:10.1080/15476286.2021.1983287 · Cited by 23

The RNA-binding protein SRSF3 has an essential role in megakaryocyte maturation and platelet production

Heazlewood, S. Y., Ahmad, T., Mohenska, M., Guo, B. B., Gangatirkar, P., Josefsson, E. C., Ellis, S. L., Ratnadiwakara, M., Cao, H., Cao, B., et al. (2021) · Blood · doi:10.1182/blood.2021013826 · Cited by 23

Convergent Clonal Evolution of Signaling Gene Mutations Is a Hallmark of Myelodysplastic Syndrome Progression

Menssen, A. J., Khanna, A., Miller, C. A., Srivatsan, S. N., Chang, G. S., Shao, J., Robinson, J., O’Laughlin, M., Fronick, C. C., Fulton, R. S., et al. (2022) · Blood Cancer Discovery · doi:10.1158/2643-3230.bcd-21-0155 · Cited by 23

Three-Dimensional Printing of an Apigenin-Loaded Mucoadhesive Film for Tailored Therapy to Oral Leukoplakia and the Chemopreventive Effect on a Rat Model of Oral Carcinogenesis

Takashima, H., Tagami, T., Kato, S., Pae, H., Ozeki, T., & Shibuya, Y. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14081575 · Cited by 23

Keeping up with the condensates: The retention, gain, and loss of nuclear membrane-less organelles

Lacroix, E., & Audas, T. E. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.998363 · Cited by 23

The Heterochromatin protein 1 is a regulator in RNA splicing precision deficient in ulcerative colitis

Mata-Garrido, J., Xiang, Y., Chang, Y., Reisacher, C., Ageron, E., Guerrera, I. C., Casafont, Í., Bruneau, A., Cherbuy, C., Tréton, X., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34556-3 · Cited by 24

Emerging treatments for myelodysplastic syndromes: Biological rationales and clinical translation

Rodríguez‐Sevilla, J. J., Ademà, V., Garcia‐Manero, G., & Colla, S. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.100940 · Cited by 23

Transcriptional reprogramming by mutated IRF4 in lymphoma

Schleußner, N., Cauchy, P., Franke, V., Giefing, M., Fornés, O., Vankadari, N., Assi, S. A., Costanza, M., Weniger, M. A., Akalin, A., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-41954-8 · Cited by 26

Cutting the cord from myelodysplastic syndromes

Padron, E., & Steensma, D. P. (2015) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000112 · Cited by 24

Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases

Voso, M. T., Fabiani, E., Fianchi, L., Falconi, G., Criscuolo, M., Santangelo, R., Chiusolo, P., Betti, S., D’Alò, F., Hohaus, S., et al. (2012) · Leukemia · doi:10.1038/leu.2012.267 · Cited by 23

Myelodysplastic syndromes in the United States: an update for clinicians

Troy, J. D., Atallah, E. L., Geyer, J. T., & Saber, W. (2014) · Annals of Medicine · doi:10.3109/07853890.2014.898863 · Cited by 23

Bone Marrow Conventional Karyotyping and Fluorescence In Situ Hybridization

He, R. L., Wiktor, A. E., Durnick, D. K., Kurtin, P. J., Dyke, D. L. V., Tefferi, A., Patnaik, M. M., Ketterling, R. P., & Hanson, C. A. (2016) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqw077 · Cited by 24

Peripheral blood cell‐free DNA is an alternative tumor DNA source reflecting disease status in myelodysplastic syndromes

Suzuki, Y., Tomita, A., Nakamura, F., Iriyama, C., Shirahata‐Adachi, M., Shimada, K., Akashi, A., Ishikawa, Y., Kaneda, N., & Kiyoi, H. (2016) · Cancer Science · doi:10.1111/cas.12994 · Cited by 23

ASXL2 mutations are frequently found in pediatric AML patients with t(8;21)/ RUNX1‐RUNX1T1 and associated with a better prognosis

Yamato, G., Shiba, N., Yoshida, K., Shiraishi, Y., Hara, Y., Ohki, K., Okubo, J., Okuno, H., Chiba, K., Tanaka, H., et al. (2017) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22443 · Cited by 24

Variant snRNPs: New players within the spliceosome system

Vazquez‐Arango, P., & O’Reilly, D. (2017) · RNA Biology · doi:10.1080/15476286.2017.1373238 · Cited by 23

Mutations in myeloproliferative neoplasms – their significance and clinical use

Schischlik, F., & Královics, R. (2017) · Expert Review of Hematology · doi:10.1080/17474086.2017.1380515 · Cited by 24

Detection of mutations in SF3B1, EIF1AX and GNAQ in primary orbital melanoma by candidate gene analysis

Rose, A. M., Luo, R., Radia, U. K., Kalirai, H., Thornton, S., Luthert, P. J., Jayasena, C. N., Verity, D. H., Coupland, S. E., & Rose, G. E. (2018) · BMC Cancer · doi:10.1186/s12885-018-5190-z · Cited by 23

Safety and activity of selinexor in patients with myelodysplastic syndromes or oligoblastic acute myeloid leukaemia refractory to hypomethylating agents: a single-centre, single-arm, phase 2 trial

Taylor, J., Mi, X., Penson, A. V., Paffenholz, S. V., Alvarez, K., Sigler, A. M., Chung, S. S., Rampal, R. K., Park, J. H., Stein, E. M., et al. (2020) · The Lancet Haematology · doi:10.1016/s2352-3026(20)30209-x · Cited by 24

Analysis of c-KIT exon 11 mutations in canine gastrointestinal stromal tumours

Takanosu, M., Amano, S., & Kagawa, Y. (2015) · The Veterinary Journal · doi:10.1016/j.tvjl.2015.10.051 · Cited by 23

Characterization of the SF3B1–SUGP1 interface reveals how numerous cancer mutations cause mRNA missplicingPreprint

Zhang, J., Xie, J., Huang, J. W., Liu, X., Xu, R., Tholen, J., Galej, W. P., Tong, L., Manley, J. L., & Liu, Z. (2023) · Genes & Development · doi:10.1101/gad.351154.123 · Cited by 25

PTEN in Regulating Hematopoiesis and Leukemogenesis

Wu, Y., Zhu, H., & Wu, H. (2020) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a036244 · Cited by 22

RNA splicing, cell signaling, and response to therapies

Fayçal, C. A., Gazzéri, S., & Eymin, B. (2015) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000254 · Cited by 22

Distinct and convergent consequences of splice factor mutations in myelodysplastic syndromes

Madan, V., Li, J., Zhou, S., Teoh, W. W., Han, L., Meggendorfer, M., Malcovati, L., Cazzola, M., Ogawa, S., Haferlach, T., et al. (2019) · American Journal of Hematology · doi:10.1002/ajh.25673 · Cited by 22

Sex-Related Differences in Chronic Myeloid Neoplasms: From the Clinical Observation to the Underlying Biology

Karantanos, T., Jain, T., Moliterno, A. R., Jones, R. J., & Dezern, A. E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052595 · Cited by 22

Nature or Nurture? Role of the Bone Marrow Microenvironment in the Genesis and Maintenance of Myelodysplastic Syndromes

Mian, S. A., & Bonnet, D. A. (2021) · Cancers · doi:10.3390/cancers13164116 · Cited by 22

SF3B1 mutation–mediated sensitization to H3B-8800 splicing inhibitor in chronic lymphocytic leukemia

López‐Oreja, I., Gohr, A., Playà-Albinyana, H., Giró, A., Arenas, F., Higashi, M., Tripathi, R., López‐Guerra, M., Irimia, M., Aymerich, M., et al. (2023) · Life Science Alliance · doi:10.26508/lsa.202301955 · Cited by 22

Regulatory role of RBM39 in acute myeloid leukemia: Mediation through the PI3K/AKT pathway

Zhang, X., Yang, L., Liu, X., Nie, Z.-Y., Liu, M., Wang, T., Lu, Y., Pan, Y., Zhan, Y., Wang, Z., et al. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2023.119607 · Cited by 23

Historical perspectives on myelodysplastic syndromes

Steensma, D. P. (2012) · Leukemia Research · doi:10.1016/j.leukres.2012.08.007 · Cited by 25

Applications of Next-Generation Sequencing to Blood and Marrow Transplantation

Chapman, M., Warren, E. H., & Wu, C. J. (2012) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2011.11.011 · Cited by 22

Epigenetic modifications of splicing factor genes in myelodysplastic syndromes and acute myeloid leukemia

Wong, J. J. L., Lau, K. A., Pinello, N., & Rasko, J. E. J. (2014) · Cancer Science · doi:10.1111/cas.12532 · Cited by 23

Molecular genetics of chronic neutrophilic leukemia, chronic myelomonocytic leukemia and atypical chronic myeloid leukemia

Li, B., Gale, R. P., & Xiao, Z. (2014) · Journal of Hematology & Oncology · doi:10.1186/s13045-014-0093-1 · Cited by 22

Engineering mouse models with myelodysplastic syndrome human candidate genes; how relevant are they?

Beurlet, S., Chomienne, C., & Padua, R. A. (2012) · Haematologica · doi:10.3324/haematol.2012.069385 · Cited by 23

The role of mRNA splicing in prostate cancer

Lapuk, A. V., Volik, S. V., Wang, Y. Z., & Collins, C. (2014) · Asian Journal of Andrology · doi:10.4103/1008-682x.127825 · Cited by 25

Activin Receptor II Ligand Traps and Their Therapeutic Potential in Myelodysplastic Syndromes with Ring Sideroblasts

Mies, A., Hermine, O., & Platzbecker, U. (2016) · Current Hematologic Malignancy Reports · doi:10.1007/s11899-016-0347-9 · Cited by 22

Molecular features of early onset adult myelodysplastic syndrome

Hirsch, C. M., Przychodzen, B. P., Radivoyevitch, T., Patel, B. J., Thota, S., Clemente, M. J., Nagata, Y., LaFramboise, T., Carraway, H. E., Nazha, A., et al. (2017) · Haematologica · doi:10.3324/haematol.2016.159772 · Cited by 22

SETBP1 mutations as a biomarker for myelodysplasia /myeloproliferative neoplasm overlap syndrome

Linder, K. J., Iragavarapu, C., & Liu, D. (2017) · Biomarker Research · doi:10.1186/s40364-017-0113-8 · Cited by 22

Distinct transcriptomic and exomic abnormalities within myelodysplastic syndrome marrow cells

Im, H., Rao, V., Sridhar, K. J., Bentley, J., Mishra, T., Chen, R., Hall, J., Graber, A., Zhang, Y., Li, X., et al. (2018) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2018.1452210 · Cited by 22

U2‐related proteins CHERP and SR140 contribute to colorectal tumorigenesis via alternative splicing regulation

Wang, Q., Wang, Y., Liu, Y., Zhang, C., Luo, Y., Guo, R., Zhan, Z., Wei, N., Xie, Z., Shen, L., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32331 · Cited by 22

A three-dimensional in vitro model of erythropoiesis recapitulates erythroid failure in myelodysplastic syndromes

Elvarsdóttir, E. M., Blanco, T. M., Dimitriou, M., Bouderlique, T., Jansson, M., Hofman, I. J., Conte, S., Karimi, M., Sander, B., Douagi, I., et al. (2019) · Leukemia · doi:10.1038/s41375-019-0532-7 · Cited by 24

Functional and conformational impact of cancer-associated SF3B1 mutations depends on the position and the charge of amino acid substitution

Canbezdi, C., Tarin, M., Houy, A., Bellanger, D., Popova, T. G., Stern, M., Roman‐Roman, S., & Alsafadi, S. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.02.012 · Cited by 22

Do polyproline II helix associations modulate biomolecular condensates?

Mompeán, M., Oroz, J., & Laurents, D. V. (2021) · FEBS Open Bio · doi:10.1002/2211-5463.13163 · Cited by 22

The diagnostic and prognostic significance of small nuclear ribonucleoprotein Sm D1 aberrantly high expression in hepatocellular carcinoma

Wang, H., Xu, F., Lu, L., Yang, F., Huang, X., Lv, L., Hu, H., & Jiang, Y. (2021) · Journal of Cancer · doi:10.7150/jca.65225 · Cited by 23

Phenotypic and genotypic characterization of azacitidine-sensitive and resistant SKM1 myeloid cell lines

Cluzeau, T., Dubois, A., Jacquel, A., Luciano, F., Renneville, A., Preudhomme, C., Karsenti, J. M., Mounier, N., Rohrlich, P., Raynaud, S., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2024 · Cited by 25

Genomic dynamics associated with malignant transformation in IDH1 mutated gliomas

Park, C., Park, I. H., Lee, S., Sun, C.-H., Koh, Y., Park, S.-H., Eun, K. J., Yun, H., & Lee, S.-H. (2015) · Oncotarget · doi:10.18632/oncotarget.6189 · Cited by 22

How Cancer Genomics Drives Cancer Biology: Does Synthetic Lethality Explain Mutually Exclusive Oncogenic Mutations?Preprint

VARMUS, H. E., Unni, A. M., & Lockwood, W. W. (2016) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2016.81.030866 · Cited by 22

Combined landscape of single-nucleotide variants and copy-number alterations in clonal hematopoiesisPreprint

Saiki, R., Momozawa, Y., Nannya, Y., Nakagawa, M. M., Ochi, Y., Yoshizato, T., Terao, C., Kuroda, Y., Shiraishi, Y., Chiba, K., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.03.05.433727 · Cited by 22

Acute myeloid leukaemia

Smith, M. L., & McKerrell, T. (2016) · Wiley eBooks · doi:10.1002/9781118527948.ch3 · Cited by 22

Mutant U2AF1-induced alternative splicing of H2afy (macroH2A1) regulates B-lymphopoiesis in mice

Kim, S. P., Srivatsan, S. N., Chavez, M., Shirai, C. L., White, B. S., Ahmed, T., Alberti, M. O., Shao, J., Nunley, R. M., White, L. S., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109626 · Cited by 23

Low-Risk Myelodysplastic Syndrome Revisited: Morphological, Autoimmune, and Molecular Features as Predictors of Outcome in a Single Center Experience

Fattizzo, B., Levati, G. V., Giannotta, J. A., Cassanello, G., Cro, L., Zaninoni, A., Barbieri, M., Croci, G. A., Revelli, N., & Barcellini, W. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.795955 · Cited by 21

Comprehensive Analysis of Acquired Genetic Variants and Their Prognostic Impact in Systemic Mastocytosis

González‐López, Ó., Muñoz‐González, J. I., Órfão, A., Álvarez‐Twöse, I., & García‐Montero, A. C. (2022) · Cancers · doi:10.3390/cancers14102487 · Cited by 21

U2AF1 pathogenic variants in myeloid neoplasms and precursor states: distribution of co-mutations and prognostic heterogeneity

Badar, T., Vanegas, Y. A. M., Nanaa, A., Foran, J. M., Al‐Kali, A., Mangaonkar, A. A., Murthy, H. S., Alkhateeb, H. B., Viswanatha, D. S., He, R. L., et al. (2023) · Blood Cancer Journal · doi:10.1038/s41408-023-00922-7 · Cited by 21

Accelerated DNA replication fork speed due to loss of R-loops in myelodysplastic syndromes with SF3B1 mutation

Rombaut, D., Lefèvre, C., Rached, T., Bondu, S., Letessier, A., Mangione, R. M., Farhat, B., Lesieur, A., Castillo-Guzman, D., Boussaid, I., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-46547-7 · Cited by 22

Regulation of TGF-β signaling, exit from the cell cycle, and cellular migration through cullin cross-regulation: SCF-FBXO11 turns off CRL4-Cdt2

Abbas, T., Keaton, M., & Dutta, A. (2013) · Cell Cycle · doi:10.4161/cc.25314 · Cited by 21

Splicing factor 3b subunit 1 (Sf3b1) haploinsufficient mice display features of low risk Myelodysplastic syndromes with ring sideroblasts

Visconte, V., Tabarroki, A., Zhang, L., Parker, Y., Hasrouni, E., Mahfouz, R. Z., Isono, K., Koseki, H., Sekeres, M. A., Saunthararajah, Y., et al. (2014) · Journal of Hematology & Oncology · doi:10.1186/s13045-014-0089-x · Cited by 24

Chronic Myelomonocytic Leukemia: a Genetic and Clinical Update

McCullough, K. B., & Patnaik, M. M. (2015) · Current Hematologic Malignancy Reports · doi:10.1007/s11899-015-0271-4 · Cited by 21

Paradoxical overexpression of MBNL2 in hepatocellular carcinoma inhibits tumor growth and invasion

Lee, Y.-H., Jhuang, Y., Chen, Y., Jeng, Y., & Yuan, R. (2016) · Oncotarget · doi:10.18632/oncotarget.11577 · Cited by 21

Gene Regulatory Network Perturbation by Genetic and Epigenetic Variation

Li, Y., McGrail, D. J., Xu, J., Mills, G. B., Sahni, N., & Yi, S. S. (2018) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2018.05.002 · Cited by 21

The evolving role of next generation sequencing in myelodysplastic syndromes

Spaulding, T. P., Stockton, S. S., & Savona, M. R. (2019) · British Journal of Haematology · doi:10.1111/bjh.16212 · Cited by 21

FLASH: ultra-fast protocol to identify RNA–protein interactions in cells

Ilik, İ., Aktaş, T., Maticzka, D., Backofen, R., & Akhtar, A. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz1141 · Cited by 22

Glucocorticoid Resistant Pediatric Acute Lymphoblastic Leukemia Samples Display Altered Splicing Profile and Vulnerability to Spliceosome Modulation

Sciarrillo, R., Wojtuszkiewicz, A., Kooi, I. E., León, L. G., Sonneveld, E., Kuiper, R. P., Jansen, G., Giovannetti, E., Kaspers, G. J. L., & Cloos, J. J. (2020) · Cancers · doi:10.3390/cancers12030723 · Cited by 21

Splicing Anomalies in Myeloproliferative Neoplasms: Paving the Way for New Therapeutic Venues

Hautin, M., Mornet, C., Chauveau, A., Bernard, D. G., Corcos, L., & Lippert, É. (2020) · Cancers · doi:10.3390/cancers12082216 · Cited by 23

A splicing factor switch controls hematopoietic lineage specification of pluripotent stem cells

Li, Y., Wang, D., Wang, H., Huang, X., Wen, Y., Wang, B., Xu, Z., Gao, J., Liu, J., Tong, J., et al. (2020) · EMBO Reports · doi:10.15252/embr.202050535 · Cited by 21

Classical Philadelphia-negative myeloproliferative neoplasms (MPNs): A continuum of different disease entities

Coltro, G., Loscocco, G. G., & Vannucchi, A. M. (2021) · International review of cytology · doi:10.1016/bs.ircmb.2021.09.001 · Cited by 25

Monocytosis and its association with clonal hematopoiesis in community-dwelling individuals

van Zeventer, I. A., de Graaf, A. O., Koorenhof‐Scheele, T. N., van der Reijden, B. A., van der Klauw, M. M., Dinmohamed, A. G., Diepstra, A., Schuringa, J. J., Malcovati, L., Huls, G. A., et al. (2022) · Blood Advances · doi:10.1182/bloodadvances.2021006755 · Cited by 21

Proteasome-Mediated Proteolysis of SRSF5 Splicing Factor Intriguingly Co-occurs with SRSF5 mRNA Upregulation during Late Erythroid Differentiation

Breig, O., & Baklouti, F. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059137 · Cited by 21

Biology of Erythropoiesis, Erythroid Differentiation, and Maturation

Papayannopoulou, T., & Migliaccio, A. R. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35762-3.00026-3 · Cited by 21

Targeting the EIF2AK1 Signaling Pathway Rescues Red Blood Cell Production in SF3B1 -Mutant Myelodysplastic Syndromes With Ringed Sideroblasts

Adema, V., Ma, F., Kanagal-Shamanna, R., Thongon, N., Montalban-Bravo, G., Yang, H., Peslak, S. A., Wang, F., Acha, P., Sole, F., et al. (2022) · Blood Cancer Discovery · doi:10.1158/2643-3230.bcd-21-0220 · Cited by 20

Prognoses of MDS subtypes RARS, RCMD and RCMD-RS are comparable but cytogenetics separates a subgroup with inferior clinical course

Bacher, U., Kern, W., Alpermann, T., Schnittger, S., Haferlach, C., & Haferlach, T. (2012) · Leukemia Research · doi:10.1016/j.leukres.2012.04.003 · Cited by 20

Optimizing hypomethylating agents in myelodysplastic syndromes

Itzykson, R., & Fenaux, P. (2012) · Current Opinion in Hematology · doi:10.1097/moh.0b013e32834ff58a · Cited by 20

Transcriptome instability as a molecular pan-cancer characteristic of carcinomas

Sveen, A., Johannessen, B., Teixeira, M. R., Lothe, R. A., & Skotheim, R. I. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-672 · Cited by 20

U2af1 is a haplo-essential gene required for hematopoietic cancer cell survival in mice

Wadugu, B. A., Srivatsan, S. N., Heard, A. D., Alberti, M. O., Ndonwi, M., Liu, J., Grieb, S., Bradley, J. L., Shao, J., Ahmed, T., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci141401 · Cited by 21

Modulation of SF3B1 in the pre-mRNA spliceosome induces a RIG-I-dependent type I IFN response

Chang, A. Y., Zhou, Y., Iyengar, S., Pobiarzyn, P. W., Tishchenko, P., Shah, K. M., Wheeler, H., Wang, Y., Loria, P. M., Loganzo, F., et al. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101277 · Cited by 20

The Coming of Age of Preclinical Models of MDS

Liu, W., Teodorescu, P., Halene, S., & Ghiaur, G. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.815037 · Cited by 20

Therapeutic Strategies to Enhance Tumor Antigenicity: Making the Tumor Detectable by the Immune System

Meraviglia-Crivelli, D., Zheleva, A., Barainka, M., Moreno, B., Villanueva, H., & Pastor, F. (2022) · Biomedicines · doi:10.3390/biomedicines10081842 · Cited by 20

Myeloid-Derived Suppressor Cells: New Insights into the Pathogenesis and Therapy of MDS

Velegraki, M., Stiff, A. R., Papadaki, H. Α., & Li, Z. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11164908 · Cited by 20

Current landscape of translational and clinical research in myelodysplastic syndromes/neoplasms (MDS): Proceedings from the 1st International Workshop on MDS (iwMDS) Of the International Consortium for MDS (icMDS)

Bewersdorf, J. P., Xie, Z., Bejar, R. L., Borate, U., Boultwood, J., Brunner, A. M., Buckstein, R. J., Carraway, H. E., Churpek, J. E., Daver, N. G., et al. (2023) · Blood Reviews · doi:10.1016/j.blre.2023.101072 · Cited by 22

SRSF2-P95H decreases JAK/STAT signaling in hematopoietic cells and delays myelofibrosis development in mice

Willekens, C., Laplane, L., Dagher, T., Benlabiod, C., Papadopoulos, N., Lacout, C., Rameau, P., Catelain, C., Alfaro, A., Edmond, V., et al. (2023) · Leukemia · doi:10.1038/s41375-023-01878-0 · Cited by 21

Citrullination and the protein code: crosstalk between post-translational modifications in cancer

Harada, K., Carr, S. M., Shrestha, A., & Thangue, N. B. L. (2023) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2022.0243 · Cited by 20

Current Outlook on Molecular Pathogenesis and Treatment of Myeloproliferative Neoplasms

Tibes, R., Bogenberger, J. M., Benson, K. L., & Mesa, R. A. (2012) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-012-0006-3 · Cited by 20

Clonal heterogeneity as a driver of disease variability in the evolution of myeloproliferative neoplasms

Prick, J. C. M., de Haan, G., Green, A. R., & Kent, D. G. (2014) · Experimental Hematology · doi:10.1016/j.exphem.2014.07.268 · Cited by 21

Abstract 5119: Frequent splicing pathway mutations and aberrant RNA splicing in myelodysplasia

Yoshida, K., Sanada, M., Shiraishi, Y., Nowak, D., Nagata, Y., Yamamoto, R., Sato, Y., Sato‐Otsubo, A., Kon, A., Nagasaki, M., et al. (2012) · Cancer Research · doi:10.1158/1538-7445.am2012-5119 · Cited by 4

Mutational Spectrum Analysis of Interesting Correlation and Interrelationship Between RNA Splicing Pathway and Commonly Targeted Genes in Myelodysplastic Syndrome

Nagata, Y., Sanada, M., Kon, A., Yoshida, K., Shiraishi, Y., Sato‐Otsubo, A., Mori, H., Ishiyama, K., Sakata‐Yanagimoto, M., Obara, N., et al. (2011) · Blood · doi:10.1182/blood.v118.21.273.273 · Cited by 3

Pathway Mutations in the Splicing Machinery in Myeloid Neoplasms

Ogawa, S. (2012) · Blood · doi:10.1182/blood.v120.21.sci-14.sci-14

Distinct and convergent consequences of splice factor mutations in myelodysplastic syndromes

Madan, V., Li, J., Zhou, S., Teoh, W. W., Han, L., Meggendorfer, M., Malcovati, L., Cazzola, M., Ogawa, S., Haferlach, T., et al. (2019) · American Journal of Hematology · doi:10.1002/ajh.25673 · Cited by 22

Splicing factor mutations in myelodysplasia

Ogawa, S. (2012) · International Journal of Hematology · doi:10.1007/s12185-012-1182-y · Cited by 38